Endocrinology

Help Shape the Future of Denosumab Treatment

As biosimilars enter the denosumab landscape, your perspective as a healthcare provider is critical in understanding what factors influence treatment decisions. This brief survey explores your views on reimbursement considerations, coding challenges, switching comfort, and drivers of biosimilar choice. As a thank you, by completing the survey, you’ll be entered into a drawing for a chance to win a $200 gift card.

Take the survey now and make your voice heard

Latest News

Dual GCG/GLP-1 Agonist Mazdutide 9 mg Produces 20% Weight Loss in Phase 3 Trial of Chinese Adults with Obesity / image courtesy of Courtesy of Peking University Health Science Center
Dual GCG/GLP-1 Agonist Mazdutide 9 mg Produces 20% Weight Loss in Phase 3 Trial of Chinese Adults with Obesity

November 20th 2025

GLORY-2 participants showed continuous weight loss through 60 weeks with no plateau; mazdutide also improved multiple cardiometabolic markers.

FDA Clears First CGM-Integrated Basal Insulin Dosing Optimizer for Adults With Type 2 Diabetes / Image credit: ©Araki Ilustrations/AdobeStock
FDA Clears First CGM-Integrated Basal Insulin Dosing Optimizer for Adults With Type 2 Diabetes

November 19th 2025

Preventive Health Inventory Boosts Diabetes and Hypertension Management Without Increasing Hospitalizations Among Veterans: New Study / Image credit: ©daniel0/AdobeStock
Preventive Health Inventory Boosts Diabetes and Hypertension Management Without Increasing Hospitalizations Among Veterans: New Study

November 18th 2025

For GLP-1 Medication Users, Investigational NK-1 Agent May Quell GI Side Effects by Half
For GLP-1 Medication Users, Investigational NK-1 Agent May Quell GI Side Effects by Half

November 18th 2025

Perimenopause Misdiagnosis Affects Nearly 40% of Women as Healthcare System Fails to Address Hormonal Roots
Perimenopause Misdiagnosis Affects Nearly 40% of Women as Clinicians Fail to Recognize Hormonal Transition

November 14th 2025

Latest CME Events & Activities

More News

© 2025 MJH Life Sciences

All rights reserved.